Qube Research & Technologies (QRT)
LXEO icon

Qube Research & Technologies (QRT)’s Lexeo Therapeutics LXEO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.41M Buy
1,376,222
+910,707
+196% +$4.93M 0.01% 1510
2026
Q1 		$2.67M Buy
465,515
+332,258
+249% +$2.35M ﹤0.01% 2001
2025
Q4 		$1.32M Buy
+133,257
New +$1.22M ﹤0.01% 2439
2024
Q1 		– Sell
-603
Closed -$8.09K – 4705
2023
Q4 		$8.09K Buy
+603
New +$7.49K ﹤0.01% 3639

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LXEO Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Lexeo Therapeutics (LXEO) stake by 196% in Q2 2026, buying an estimated $4.93M and bringing the position to 1,376,222 shares worth $6.41M. The position accounts for 0.01% of the portfolio, ranked #1510.

Qube Research & Technologies (QRT) first reported a position in LXEO in Q4 2023 and has held it in 4 quarters since. 142 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Qube Research & Technologies (QRT) held 1,376,222 shares of Lexeo Therapeutics worth $6.41M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 910,707 Lexeo Therapeutics shares in Q2 2026, an estimated $4.93M.
  • Lexeo Therapeutics made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1510 holding.
  • Qube Research & Technologies (QRT) first reported a position in Lexeo Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • 142 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.